Apr 23, 2017
I'm always a little shocked when I see how much venture investing goes into the healthcare space, which brings me to the subject of this week's episode: just how the healthcare industry is (and isn't) being impacted by innovations in AI technology. Guest Steve Gullans of Boston-Based Excel Venture Management talks about some of the various healthcare-related ML and AI applications that he sees being brought to light, and touches on which innovations have a better chance of getting blocked and redirected by parties of interest and those that have more promise in being accepted and rolled out sooner. By the end of this episode, listeners will have a more clear picture of practical considerations in healthcare technology adoption, reasons that are often less about quality or potential of the technology and more about clarity on ROI for investors.